Article
Copy-number intratumor heterogeneity contributes to predict relapse in chemotherapy-naive stage II colon cancer
2021-04-17
Abstract excerpt
<h4>ABSTRACT</h4> Optimal selection of high-risk patients with stage II colon cancer is crucial to ensure clinical benefit of adjuvant chemotherapy after surgery. Here, we investigate the prognostic and predictive value of genomic intratumor heterogeneity and aneuploidy for disease recurrence. We combined SNP arrays, targeted next-generation sequencing, fluorescence in situ hybridization and inmunohistochemistry...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 631a1710-4daf-51c5-93e2-a447b7106e13
- DOI
- 10.1101/2021.04.16.440177
